EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Pain Current Understanding Emerging Therapies And Novel Approaches To Drug Discovery 1st Edition Chas Bountra

Name: Pain Current Understanding Emerging Therapies And Novel Approaches To Drug Discovery 1st Edition Chas Bountra
SKU: BELL-2195096
Price: 31.00 USD
Availability: InStock
Rating: 5 (58 reviews)

SKU: BELL-2195096

$ 31.00 ~~$ 45.00~~ (-31%)

5.0

58 reviews

Pain Current Understanding Emerging Therapies And Novel Approaches To Drug Discovery 1st Edition Chas Bountra instant download after payment.

Publisher: Informa Healthcare

File Extension: PDF

File size: 10.52 MB

Pages: 939

Author: Chas Bountra, Rajesh Munglani, William K. Schmidt

ISBN: 0824788656, 9780824788650

Language: English

Year: 2003

Edition: 1

Product desciption

Pain Current Understanding Emerging Therapies And Novel Approaches To Drug Discovery 1st Edition Chas Bountra by Chas Bountra, Rajesh Munglani, William K. Schmidt 0824788656, 9780824788650 instant download after payment.

This reference presents a detailed overview of approaches and techniques in the management of pain caused by tissue, nerve and central nervous system injuries, categorizing pain into a variety of syndromes and underlying mechanisms to aid the development of interventional pharmacologic measures.